Search for: "K " Results 181 - 200 of 51,794
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 May 2024, 9:05 pm by renholding
Last February, the European Council and the European Parliament reached a final compromise on an EU Listing Act.[1] The act aims to make listings in the EU – and raising capital through the stock market – more attractive by simplifying and harmonizing the listing rules. [read post]
1 May 2024, 2:56 pm by Yosi Yahoudai
Innovation Park would also include a K-8 school, parks, businesses and 2,500 homes. [read post]
1 May 2024, 12:36 am by Tom Mayo
The New Yorker has posted an excellent essay ("How ECMO is Redefining Death") on the history, current status, and ethical challenges of extracorporeal membrane oxygenation (a/k/a ECMO), an out-of-body device that bypasses the heart and lungs by taking carbon dioxide out of a patient's blood, oxygenating it, and returning the blood to the patient's circulatory system. [read post]
30 Apr 2024, 3:12 pm by Bill Marler
 Sources, Characteristics and Identification E. coli is an archetypal commensal bacterial species that lives in mammalian intestines. [read post]
30 Apr 2024, 3:12 pm by Parks, Chesin & Walbert
In addition to misclassification, other problem areas in construction that the WHD has identified include: not paying for all hours actually worked (including work done before or after the shift, as well as compensable downtime or meal breaks,) “banking” (a/k/a converting overtime hours into “comp time,” and failing to pay for travel from the shop to the work-site and back. [read post]
30 Apr 2024, 12:44 pm by Daily Record Staff
As a new partner in the Baltimore Library Project, Learning Undefeated will serve 10 K-8 schools this year, including the Maryland School for the Blind. [read post]
30 Apr 2024, 3:10 am by Zack Peckham, Health-E Commerce
An HSA Future Value Calculator can help employees project the future value of their account, while an HSA and 401(k) Maximizer can help employees determine how the accounts can collectively support their savings goals. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm by Sherica Celine
New and Updated Practical Guidance Content 401(k) and Other Defined Contribution Plan Compliance Resource Kit Form 5500 Annual Reports Executive and Director Perquisites Benchmarking 401(k) Plans Video Cybersecurity Best Practices in Retirement Plans Checklist Retention Bonus and Change in Control Agreement PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB Experience results today with practical guidance, legal research, and data-driven insights—all in one place. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 10:00 pm
This guidance provides specific recommendations for all three classes of products—biologics approved under 351(a) of the Public Health Service Act (PHS Act), and biosimilar products and interchangeable biosimilar products approved under 351(k) of the PHS Act—with respect to meeting FDA’s general accuracy and truthful and non-misleading standards that are applied to advertising and promotion of prescription drug products generally. [read post]
29 Apr 2024, 9:01 pm by Vikram David Amar and Jason Mazzone
During the Trump administration, various K-12 schools around the country suspended or otherwise punished students for wearing MAGA attire in particular to class in circumstances that suggest at least the possibility of viewpoint discrimination. [read post]